The observation is also consistent with the finding that the myeloid growth factor GM-CSF (granulocyte–macrophage colony–stimulating factor) and the monocyte/macrophage chemoattractant MCP-1 are elevated in blood and are associated with COVID-19 severity (36, 37). The gene discussed is CCL2; the disease is COVID-19.